00000nam 2200000za 4500 9.573626 CaOODSP 20210624183805 cr ||||||||||| 150406t19981997cn ad|||o f000 0 eng d 0-662-26385-5 CaOODSP eng n-cn--- H42-2/67-12-1997E-PDF General considerations for clinical trials [electronic resource]. At head of title: ICH Harmonised Tripartite guideline : International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Ottawa : Therapeutic Products Directorate, Health Canada. 1998, c1997. ii, 22 p. : ill. Therapeutic Products Directorate guidelines "ICH Harmonised Tripartite guideline, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use." Incorrect catalogue number (H42-2/67-12-1997IN) recorded in this electronic publication. 12-14-Supp 2012-04-10 Canada. Health Canada. Therapeutic Products Directorate. Considérations générales relatives aux études cliniques : (CaOODSP)9.603737 ICH harmonized tripartite guideline: general consideration for clinical trials : (CaOODSP)9.614224 Therapeutic Products Directorate guidelines. (CaOODSP)9.506920 http://publications.gc.ca PDF 105 KB https://publications.gc.ca/collections/Collection/H42-2-67-12-1997E.pdf